The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem
| Autor: | Andrew Kewley, Adrian Baldwin, Jonathan C. W. Edwards, Mark Livingstone, Simon McGrath |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty business.industry Encephalomyelitis Public Health Environmental and Occupational Health Alternative medicine Medicine (miscellaneous) Institute of medicine medicine.disease 3. Good health 03 medical and health sciences Behavioral Neuroscience Editorial 030104 developmental biology 0302 clinical medicine Quality of life (healthcare) Research community medicine Chronic fatigue syndrome Psychiatry business 030217 neurology & neurosurgery |
| Zdroj: | Fatigue |
| ISSN: | 2164-1862 2164-1846 |
| DOI: | 10.1080/21641846.2016.1160598 |
| Popis: | Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is comparable to multiple sclerosis, diabetes or rheumatoid arthritis in prevalence (∼0.2% to 1%), long-term disability, and quality of life,[1–5] yet the scale of biomedical research and funding has been pitifully limited, as the recent National Institutes of Health (NIH) and Institute of Medicine reports highlight.[6,7] Recently in the USA, NIH Director Francis Collins has stated that the NIH will be ramping up its efforts and levels of funding for ME/CFS,[8] which we hope will greatly increase the interest in, and resources for researching this illness. Despite scant funding to date, researchers in the field have generated promising leads that throw light on this previously baffling illness. We suggest the key elements of a concerted research programme and call on the wider biomedical research community to actively target this condition. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |